Literature DB >> 64712

Necropsy evidence of central cholinergic deficits in senile dementia.

E K Perry, R H Perry, G Blessed, B E Tomlinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 64712     DOI： 10.1016/s0140-6736(77)91780-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  114 in total

Review 1.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

2.  Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease.

Authors:  Denise Harold; Timothy Peirce; Valentina Moskvina; Amanda Myers; Susan Jones; Paul Hollingworth; Pamela Moore; Simon Lovestone; John Powell; Catherine Foy; Nicola Archer; Sarah Walter; Amanda Edmonson; Stephen McIlroy; David Craig; Peter A Passmore; Alison Goate; John Hardy; Michael O'Donovan; Julie Williams; Malcolm Liddell; Michael J Owen; Lesley Jones
Journal:  Hum Genet       Date:  2003-05-21       Impact factor: 4.132

Review 3.  Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.

Authors:  Gregory J Digby; Jana K Shirey; P Jeffrey Conn
Journal:  Mol Biosyst       Date:  2010-06-25

4.  Effects of ZK 93426 on muscarinic and nicotinic antagonist or nucleus basalis lesioning-induced electrocortical slowing.

Authors:  P Riekkinen; M Riekkinen; J Sirviö; P Riekkinen
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.

Authors:  A Little; R Levy; P Chuaqui-Kidd; D Hand
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-08       Impact factor: 10.154

Review 6.  Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment.

Authors:  C G Gottfries
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Evidence for an increased rate of choline efflux across erythrocyte membranes in Alzheimer's disease.

Authors:  D A Butterfield; M M Nicholas; W R Markesbery
Journal:  Neurochem Res       Date:  1985-07       Impact factor: 3.996

Review 8.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

9.  Trans-synaptic stimulation of cortical acetylcholine release after partial 192 IgG-saporin-induced loss of cortical cholinergic afferents.

Authors:  J Fadel; H Moore; M Sarter; J P Bruno
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

10.  Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core.

Authors:  M N Rossor
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.